DAVID P KING Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for DAVID P KING.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DAVID P KING. DAVID P KING is President & CEO in LABORATORY CORP OF AMERICA HOLDINGS ($LH).
Latest Insider Trading Transactions of DAVID P KING
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 17 2015 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | M | 0.00 | 8,270 | 0 | 24,957 | |
| Feb 17 2015 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Payment of Exercise | F | 116.84 | 3,945 | 460,934 | 65,058 | 69 K to 65.1 K (-5.72 %) |
| Feb 17 2015 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Buy | M | 0.00 | 8,270 | 0 | 69,003 | 60.7 K to 69 K (+13.62 %) |
| Feb 13 2015 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | M | 0.00 | 8,343 | 0 | 33,227 | |
| Feb 13 2015 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Payment of Exercise | F | 116.73 | 3,262 | 380,773 | 60,733 | 64 K to 60.7 K (-5.10 %) |
| Feb 13 2015 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Buy | M | 0.00 | 8,343 | 0 | 63,995 | 55.7 K to 64 K (+14.99 %) |
| Sep 24 2014 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | M | 75.63 | 65,234 | 4,933,647 | 0 | |
| Sep 24 2014 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Sell | S | 105.58 | 4,700 | 496,224 | 55,583 | 60.3 K to 55.6 K (-7.80 %) |
| Sep 24 2014 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Sell | S | 104.64 | 60,534 | 6,334,532 | 60,283 | 120.8 K to 60.3 K (-50.10 %) |
| Sep 24 2014 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Buy | M | 75.63 | 65,234 | 4,933,647 | 120,817 | 55.6 K to 120.8 K (+117.36 %) |
| Aug 26 2014 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | M | 75.63 | 65,233 | 4,933,572 | 65,234 | |
| Aug 26 2014 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Sell | S | 106.10 | 65,233 | 6,921,450 | 55,583 | 120.8 K to 55.6 K (-53.99 %) |
| Aug 26 2014 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Buy | M | 75.63 | 65,233 | 4,933,572 | 120,816 | 55.6 K to 120.8 K (+117.36 %) |
| Jul 24 2014 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | M | 75.63 | 65,233 | 4,933,572 | 130,467 | |
| Jul 24 2014 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Sell | S | 105.99 | 1,600 | 169,584 | 55,583 | 57.2 K to 55.6 K (-2.80 %) |
| Jul 24 2014 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Sell | S | 105.54 | 63,633 | 6,715,827 | 57,183 | 120.8 K to 57.2 K (-52.67 %) |
| Jul 24 2014 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Buy | M | 75.63 | 65,233 | 4,933,572 | 120,816 | 55.6 K to 120.8 K (+117.36 %) |
| Mar 31 2014 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Payment of Exercise | F | 97.87 | 7,193 | 703,979 | 70,147 | 77.3 K to 70.1 K (-9.30 %) |
| Mar 31 2014 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Grant | A | 0.00 | 15,063 | 0 | 77,340 | 62.3 K to 77.3 K (+24.19 %) |
| Mar 04 2014 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Payment of Exercise | F | 93.54 | 3,518 | 329,074 | 62,277 | 65.8 K to 62.3 K (-5.35 %) |
| Feb 13 2014 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | M | 0.00 | 8,270 | 0 | 41,570 | |
| Feb 13 2014 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | A | 0.00 | 25,030 | 0 | 49,840 | |
| Feb 13 2014 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Payment of Exercise | F | 90.98 | 3,949 | 359,280 | 65,795 | 69.7 K to 65.8 K (-5.66 %) |
| Feb 13 2014 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Buy | M | 0.00 | 8,270 | 0 | 69,744 | 61.5 K to 69.7 K (+13.45 %) |
| Feb 12 2014 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Payment of Exercise | F | 91.35 | 2,225 | 203,254 | 61,474 | 63.7 K to 61.5 K (-3.49 %) |
| Jan 29 2014 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | M | 60.04 | 24,200 | 1,452,968 | 0 | |
| Jan 29 2014 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Sell | S | 90.15 | 24,200 | 2,181,637 | 63,699 | 87.9 K to 63.7 K (-27.53 %) |
| Jan 29 2014 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Buy | M | 60.04 | 24,200 | 1,452,968 | 87,899 | 63.7 K to 87.9 K (+37.99 %) |
| Dec 27 2013 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | M | 60.04 | 25,000 | 1,501,000 | 24,200 | |
| Dec 27 2013 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Sell | S | 90.79 | 25,000 | 2,269,750 | 63,628 | 88.6 K to 63.6 K (-28.21 %) |
| Dec 27 2013 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Buy | M | 60.04 | 25,000 | 1,501,000 | 88,628 | 63.6 K to 88.6 K (+39.29 %) |
| Nov 27 2013 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | M | 60.04 | 25,000 | 1,501,000 | 49,200 | |
| Nov 27 2013 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Sell | S | 106.01 | 25,000 | 2,650,293 | 63,628 | 88.6 K to 63.6 K (-28.21 %) |
| Nov 27 2013 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Buy | M | 60.04 | 25,000 | 1,501,000 | 88,628 | 63.6 K to 88.6 K (+39.29 %) |
| Oct 28 2013 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | M | 60.04 | 25,000 | 1,501,000 | 74,200 | |
| Oct 28 2013 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Sell | S | 101.51 | 4,413 | 447,983 | 63,628 | 68 K to 63.6 K (-6.49 %) |
| Oct 28 2013 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Sell | S | 100.78 | 20,587 | 2,074,820 | 68,041 | 88.6 K to 68 K (-23.23 %) |
| Oct 28 2013 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Buy | M | 60.04 | 25,000 | 1,501,000 | 88,628 | 63.6 K to 88.6 K (+39.29 %) |
| Jul 26 2013 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | M | 60.04 | 25,000 | 1,501,000 | 149,200 | |
| Jul 26 2013 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Sell | S | 97.72 | 25,000 | 2,442,898 | 63,628 | 88.6 K to 63.6 K (-28.21 %) |
| Jul 26 2013 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Buy | M | 60.04 | 25,000 | 1,501,000 | 88,628 | 63.6 K to 88.6 K (+39.29 %) |
| Sep 27 2013 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | M | 60.04 | 25,000 | 1,501,000 | 99,200 | |
| Sep 27 2013 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Sell | S | 99.06 | 25,000 | 2,476,615 | 63,628 | 88.6 K to 63.6 K (-28.21 %) |
| Sep 27 2013 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Buy | M | 60.04 | 25,000 | 1,501,000 | 88,628 | 63.6 K to 88.6 K (+39.29 %) |
| Aug 28 2013 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | M | 60.04 | 25,000 | 1,501,000 | 124,200 | |
| Aug 28 2013 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Sell | S | 96.60 | 25,000 | 2,415,048 | 63,628 | 88.6 K to 63.6 K (-28.21 %) |
| Aug 28 2013 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Buy | M | 60.04 | 25,000 | 1,501,000 | 88,628 | 63.6 K to 88.6 K (+39.29 %) |
| Jun 26 2013 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | M | 60.04 | 25,000 | 1,501,000 | 174,200 | |
| Jun 26 2013 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Sell | S | 99.06 | 300 | 29,718 | 63,423 | 63.7 K to 63.4 K (-0.47 %) |
| Jun 26 2013 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Sell | S | 99.05 | 400 | 39,620 | 63,723 | 64.1 K to 63.7 K (-0.62 %) |
| Jun 26 2013 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Sell | S | 98.65 | 24,300 | 2,397,195 | 64,123 | 88.4 K to 64.1 K (-27.48 %) |
| Jun 26 2013 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Buy | M | 60.04 | 25,000 | 1,501,000 | 88,423 | 63.4 K to 88.4 K (+39.42 %) |
| Apr 01 2013 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Payment of Exercise | F | 90.20 | 17,180 | 1,549,636 | 63,423 | 80.6 K to 63.4 K (-21.31 %) |
| Apr 01 2013 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Grant | A | 0.00 | 35,827 | 0 | 80,603 | 44.8 K to 80.6 K (+80.01 %) |
| Mar 04 2013 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Payment of Exercise | F | 88.60 | 3,533 | 313,024 | 44,776 | 48.3 K to 44.8 K (-7.31 %) |
| Feb 14 2013 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | A | 0.00 | 24,810 | 0 | 24,810 | |
| Feb 13 2013 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Payment of Exercise | F | 90.06 | 1,983 | 178,589 | 48,309 | 50.3 K to 48.3 K (-3.94 %) |
| Feb 13 2013 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Payment of Exercise | F | 90.06 | 2,132 | 192,008 | 50,292 | 52.4 K to 50.3 K (-4.07 %) |
| Jul 11 2012 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | M | 60.04 | 49,800 | 2,989,992 | 199,200 | |
| Jul 11 2012 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | M | 58.57 | 35,000 | 2,049,950 | 0 | |
| Jul 11 2012 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Sell | S | 92.11 | 84,800 | 7,810,928 | 110,232 | 195 K to 110.2 K (-43.48 %) |
| Jul 11 2012 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Buy | M | 60.04 | 49,800 | 2,989,992 | 195,032 | 145.2 K to 195 K (+34.29 %) |
| Jul 11 2012 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Buy | M | 58.57 | 35,000 | 2,049,950 | 145,232 | 110.2 K to 145.2 K (+31.75 %) |
| Jul 05 2012 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Gift | G | 0.00 | 43,758 | 0 | 43,758 | 0 to 43.8 K |
| Jul 05 2012 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Gift | G | 0.00 | 43,758 | 0 | 110,232 | 154 K to 110.2 K (-28.42 %) |
| May 29 2012 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | A | 84.86 | 149,900 | 12,720,514 | 149,900 | |
| Mar 28 2012 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Payment of Exercise | F | 91.90 | 27,690 | 2,544,711 | 153,784 | 181.5 K to 153.8 K (-15.26 %) |
| Mar 28 2012 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Grant | A | 0.00 | 65,228 | 0 | 181,474 | 116.2 K to 181.5 K (+56.11 %) |
| Mar 01 2012 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Grant | A | 0.00 | 22,100 | 0 | 116,246 | 94.1 K to 116.2 K (+23.47 %) |
| Feb 13 2012 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Payment of Exercise | F | 90.03 | 3,170 | 285,395 | 94,146 | 97.3 K to 94.1 K (-3.26 %) |
| Feb 13 2012 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Payment of Exercise | F | 92.11 | 2,363 | 217,656 | 97,316 | 99.7 K to 97.3 K (-2.37 %) |
| Feb 13 2012 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Payment of Exercise | F | 92.11 | 2,358 | 217,195 | 99,679 | 102 K to 99.7 K (-2.31 %) |
| Jan 27 2012 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | M | 58.57 | 20,000 | 1,171,400 | 35,000 | |
| Jan 27 2012 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Sell | S | 92.00 | 20,000 | 1,840,000 | 102,037 | 122 K to 102 K (-16.39 %) |
| Jan 27 2012 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Buy | M | 58.57 | 20,000 | 1,171,400 | 122,037 | 102 K to 122 K (+19.60 %) |
| Dec 06 2011 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | M | 47.89 | 20,000 | 957,800 | 0 | |
| Dec 06 2011 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Sell | S | 88.00 | 20,000 | 1,760,000 | 101,957 | 122 K to 102 K (-16.40 %) |
| Dec 06 2011 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Buy | M | 47.89 | 20,000 | 957,800 | 121,957 | 102 K to 122 K (+19.62 %) |
| Apr 27 2011 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Sell | S | 95.86 | 7,254 | 695,368 | 101,765 | 109 K to 101.8 K (-6.65 %) |
| Apr 01 2011 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Payment of Exercise | F | 91.57 | 10,702 | 979,982 | 109,019 | 119.7 K to 109 K (-8.94 %) |
| Apr 01 2011 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Grant | A | 0.00 | 25,210 | 0 | 119,721 | 94.5 K to 119.7 K (+26.67 %) |
| Feb 16 2011 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Payment of Exercise | F | 87.73 | 2,435 | 213,623 | 94,511 | 96.9 K to 94.5 K (-2.51 %) |
| Feb 11 2011 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | A | 90.74 | 177,400 | 16,097,276 | 177,400 | |
| Feb 11 2011 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Payment of Exercise | F | 87.73 | 2,692 | 236,169 | 96,946 | 99.6 K to 96.9 K (-2.70 %) |
| Feb 11 2011 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Grant | A | 0.00 | 16,700 | 0 | 99,638 | 82.9 K to 99.6 K (+20.14 %) |
| Feb 11 2011 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Payment of Exercise | F | 90.74 | 2,077 | 188,467 | 82,938 | 85 K to 82.9 K (-2.44 %) |
| Apr 21 2010 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | M | 47.89 | 10,000 | 478,900 | 20,000 | |
| Apr 21 2010 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Sell | S | 80.00 | 10,000 | 800,000 | 84,682 | 94.7 K to 84.7 K (-10.56 %) |
| Apr 21 2010 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Sell | S | 79.00 | 1,370 | 108,230 | 94,682 | 96.1 K to 94.7 K (-1.43 %) |
| Apr 21 2010 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Buy | M | 47.89 | 10,000 | 478,900 | 96,052 | 86.1 K to 96.1 K (+11.62 %) |
| Apr 05 2010 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Sell | S | 77.00 | 3,500 | 269,500 | 86,052 | 89.6 K to 86.1 K (-3.91 %) |
| Mar 29 2010 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | M | 39.00 | 30,000 | 1,170,000 | 0 | |
| Mar 29 2010 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Sell | S | 74.05 | 30,000 | 2,221,590 | 89,552 | 119.6 K to 89.6 K (-25.09 %) |
| Mar 29 2010 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Sell | S | 74.16 | 2,500 | 185,400 | 119,552 | 122.1 K to 119.6 K (-2.05 %) |
| Mar 29 2010 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Sell | S | 75.00 | 1,372 | 102,900 | 122,052 | 123.4 K to 122.1 K (-1.11 %) |
| Mar 29 2010 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Buy | M | 39.00 | 30,000 | 1,170,000 | 123,424 | 93.4 K to 123.4 K (+32.11 %) |
| Feb 24 2010 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Payment of Exercise | F | 73.97 | 3,464 | 256,232 | 93,424 | 96.9 K to 93.4 K (-3.58 %) |
| Feb 18 2010 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Payment of Exercise | F | 72.43 | 1,861 | 134,792 | 96,888 | 98.7 K to 96.9 K (-1.88 %) |
| Feb 11 2010 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | A | 70.15 | 196,400 | 13,777,460 | 196,400 | |
| Feb 11 2010 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Payment of Exercise | F | 70.97 | 2,423 | 171,960 | 98,749 | 101.2 K to 98.7 K (-2.39 %) |
| Feb 11 2010 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Grant | A | 0.00 | 19,200 | 0 | 101,172 | 82 K to 101.2 K (+23.42 %) |
| Feb 24 2009 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Payment of Exercise | F | 62.12 | 1,840 | 114,301 | 83,141 | 85 K to 83.1 K (-2.17 %) |
| Feb 24 2009 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Payment of Exercise | F | 62.51 | 3,538 | 221,160 | 84,981 | 88.5 K to 85 K (-4.00 %) |
| Feb 17 2009 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Payment of Exercise | F | 62.42 | 1,861 | 116,164 | 88,519 | 90.4 K to 88.5 K (-2.06 %) |
| Feb 13 2009 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | A | 60.04 | 249,000 | 14,949,960 | 249,000 | |
| Feb 13 2009 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Grant | A | 60.04 | 22,400 | 1,344,896 | 90,380 | 68 K to 90.4 K (+32.95 %) |
Page: 1